MedTrace Logo

Multiple-biomarker Approach for Individualized Treatment of Heart Failure with Preserved Ejection Fraction

NCT06785506 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-01-21

No results posted yet for this study

Summary

The primary objective is to investigate the association between temporal evolutions of blood biomarkers and clinical adverse events, in order to produce a dynamic, individual, and accurate prediction model for patients with HFpEF.

Moreover several secondary objectives will be investigated.

Conditions

Sponsors & Collaborators

  • Ikazia Hospital, Rotterdam

    collaborator OTHER

  • Franciscus Gasthuis & Vlietland (Hospital)

    collaborator OTHER

  • OLVG

    collaborator NETWORK

  • Free University Medical Center

    collaborator OTHER

  • Noordwest Ziekenhuisgroep

    collaborator OTHER

  • Erasmus Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-25
Primary Completion
2026-09-01
Completion
2026-09-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06785506 on ClinicalTrials.gov